SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Oncology Drug Shortages Persist, but Continue to Evolve

2.

New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations

3.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

4.

Novel analysis identifies markers that may predict failure of metastatic prostate cancer treatment

5.

Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot